- Home
- AMED
AMED
Amedisys Inc
as 04-25-2025 4:00pm EST
Amedisys Inc is a healthcare services company in the United States. The company brings healthcare to the home through the provision of home healthcare services, hospice services, and high acuity care segment. The Home Health Segment provides skilled nurses, therapists, and aids to patients' homes throughout the United States; the Hospice segment operates many centers designed to provide comfort and support for terminally ill patients; and the High acuity care segment can deliver the essential elements of inpatient hospital, SNF care, and palliative care to patients in their homes. A majority of the company's revenue is derived from the Home Health segment.
| Founded: | 1982 | Country: | United States |
| Employees: | N/A | City: | BATON ROUGE |
| Market Cap: | 3.0B | IPO Year: | N/A |
| Target Price: | $100.80 | AVG Volume (30 days): | 322.3K |
| Analyst Decision: | Hold | Number of Analysts: | 6 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 2.72 | EPS Growth: | N/A |
| 52 Week Low/High: | $82.15 - $98.95 | Next Earning Date: | 04-23-2025 |
| Revenue: | $2,371,691,000 | Revenue Growth: | 5.34% |
| Revenue Growth (this year): | 6.54% | Revenue Growth (next year): | 5.32% |
Stock Insider Trading Activity of Amedisys Inc (AMED)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Guidroz Allyson | AMED | Chief Accounting Officer | Mar 4 '25 | Sell | $92.03 | 2,041 | $187,833.23 | 8,761 |
Latest Amedisys Inc News
AMED Breaking Stock News: Dive into AMED Ticker-Specific Updates for Smart Investing
Zacks
2 days ago
AMED Stock Trades Flat Despite Q1 Earnings Beat, Margins Rise
Zacks
2 days ago
Compared to Estimates, Amedisys (AMED) Q1 Earnings: A Look at Key Metrics
Zacks
2 days ago
Amedisys (AMED) Tops Q1 Earnings Estimates
Associated Press Finance
2 days ago
Amedisys: Q1 Earnings Snapshot
GlobeNewswire
2 days ago
Amedisys Reports First Quarter 2025 Financial Results
Argus Research
3 days ago
AMED: Raising target price to $97.00
Zacks
10 days ago
Amedisys (AMED) Earnings Expected to Grow: Should You Buy?
Argus Research
10 days ago
AMED: What does Argus have to say about AMED?
Compare AMED vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "AMED Amedisys Inc - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.